Sara Ekberg (S Ekberg)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Topics

Multiple Myeloma

Diffuse Large B Cell Lymphoma

Prognostic Factors

Placebo Controlled

Top Venues

British journal of haematology

American journal of hematology

British journal of cancer

Journal of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Harrysson, Sandra Eloranta, Sara Ekberg, Gunilla Enblad, Tarec C El-Galaly, Birgitta Sander, Kristina Sonnevi, Per-Ola Andersson, Mats Jerkeman, Karin E Smedby
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients. British journal of haematology 198 (2) (2022)
Sara Ekberg, Karin Ekström Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline E Weibull, Ingrid Glimelius
Late effects in mantle cell lymphoma patients treated with or without autologous stem cell transplantation. Blood advances (2022)
Sara Ekberg, Michael Crowther, Sara Harrysson, Mats Jerkeman, Karin E Smedby, Sandra Eloranta
Patient trajectories after diagnosis of diffuse large B-cell lymphoma-a multistate modelling approach to estimate the chance of lasting remission. British journal of cancer 127 (9) (2022)
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M Birmann, Karin E Smedby
Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era. British journal of haematology 195 (4) (2021)
Sara Ekberg, Sara Harrysson, Tomas Jernberg, Karolina Elisabeth Szummer, P-O Andersson, Mats Jerkeman, Karin E Smedby, Sandra Eloranta
Myocardial infarction in diffuse large B-cell lymphoma patients - a population-based matched cohort study. Journal of internal medicine 290 (5) (2021)
Karin Fjordén, Sara Ekberg, Nevzeta Kuric, Karin E Smedby, Ingemar Lagerlöf, Thomas S Larsen, Judit M Jørgensen, Peter de Nully Brown, Mats Jerkeman
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial. British journal of haematology (2021)
Elsa Brånvall, Sara Ekberg, Sandra Eloranta, Tove Wästerlid, Brenda M Birmann, Karin E Smedby
Statin use is associated with improved survival in multiple myeloma: A Swedish population-based study of 4315 patients. American journal of hematology 95 (6) (2020)
Sara Ekberg, Karin E Smedby, Ingrid Glimelius, Herman Nilsson-Ehle, Christina Goldkuhl, Catharina Lewerin, Mats Jerkeman, Sandra Eloranta
Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study. British journal of haematology 189 (6) (2020)
Tove Wästerlid, Sara Harrysson, Therese M-L Andersson, Sara Ekberg, Gunilla Enblad, Per-Ola Andersson, Mats Jerkeman, Sandra Eloranta, Karin E Smedby
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma. American journal of hematology 95 (7) (2020)
Elin Dahlén, Sara Ekberg, Cecilia Lundholm, Eva Wikström Jonsson, Inger Kull, Björn Wettermark, Catarina Almqvist
Sibship and dispensing patterns of asthma medication in young children-a population-based study. Pharmacoepidemiology and drug safety 28 (8) (2019)
Sara Ekberg, Mats Jerkeman, Per-Ola Andersson, Gunilla Enblad, Björn E Wahlin, Sverker Hasselblom, Therese M Andersson, Sandra Eloranta, Karin E Smedby
Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma. American journal of hematology (2018)